He will be leading the design and execution of transformative strategies that harness the power of AI and automation, drive process optimization, and ignite digital innovation
The approval is based on a comprehensive package of analytical, nonclinical, and clinical data
MET-X, a novel metallo-beta-lactamase (MBL) inhibitor, has shown best-in-class performance in preclinical studies
Sun Pharma will have the exclusive worldwide rights to commercialise Fibromun
Oscotec has successfully completed phase 2 study in patients with chronic ITP last year
Proposed acquisition represents meaningful step forward in Biogen’s strategy for sustainable growth
CHMP recommendation is based on Phase III data, which demonstrated that darolutamide plus androgen deprivation therapy (ADT) in combination with docetaxel significantly reduced the risk of death by 32.5%
Dr. Bibikova is an international leader with over 25 years of experience in genomics industry
Subscribe To Our Newsletter & Stay Updated
